Table 3 Pathologic stage of esophageal neuroendocrine carcinomas
Pure NECs+(%) | MiNECs+(%) | P | |
|---|---|---|---|
Total number | 35(97.2) | 16(94.1) | |
pT | 0.021 | ||
1a | 0(0.0) | 0(0.0) | |
1b | 8(22.9) | 1(6.25) | |
2 | 15(42.9) | 4(25.0) | |
3 | 12(34.3) | 11(68.8) | |
4 | 0(0.0) | 0(0.0) | |
pN | 0.194 | ||
0 | 23(65.7) | 7(43.8) | |
1 | 6(17.1) | 5(31.3) | |
2 | 5(14.3) | 4(25.0) | |
3 | 1(2.9) | 0(0.0) | |
pM | 1.000 | ||
0 | 32(91.4) | 14(87.5) | |
1 | 3(8.6) | 2(12.5) | |
Summary stage | 0.129 | ||
IA | 0(0.0) | 0(0.0) | |
IB | 7(20.0) | 0(0.0) | |
IIA | 15(42.9) | 7(43.8) | |
IIB | 0(0.0) | 1(6.25) | |
IIIA | 2(5.7) | 1(6.25) | |
IIIB | 7(20.0) | 5(31.25) | |
IVA | 1(2.9) | 0(0.0) | |
IVB | 3(8.6) | 2(12.5) |